Building Blocks
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,778 products)
- Chiral Building Blocks(1,243 products)
- Hydrocarbon Building Blocks(6,099 products)
- Organic Building Blocks(61,038 products)
Found 205376 products of "Building Blocks"
2-Azabicyclo[3.2.2]nonan-3-one
CAS:Versatile small molecule scaffoldFormula:C8H13NOPurity:Min. 95%Molecular weight:139.19 g/mol5-Bromo-2,3-dihydro-1-benzofuran-3-ol
CAS:Versatile small molecule scaffoldFormula:C8H7BrO2Purity:Min. 95%Molecular weight:215.04 g/molrac-(1R,2R)-2-Phenylcyclopropane-1-carbonitrile
CAS:Rac-1R,2R-2-phenylcyclopropane-1-carbonitrile is an enantiopure compound with two chiral centers. It is a reaction intermediate in the synthesis of prodrugs for the treatment of cancer. Rac-1R,2R-2-phenylcyclopropane-1-carbonitrile is converted to its corresponding amide by reaction with ammonia and then reacted with hydrochloric acid to form the corresponding ester. The optical purity of rac-(1R,2R)-2-phenylcyclopropane-1-carbonitrile can be determined by measuring the optical rotation of the chiral center at 366 nm. Rac-(1R,2R)-2-phenylcyclopropane-1-carbonitrile has a spontaneous rate constant of k=0.02±0.001 s−1 and an additivity parameter of ΔH=-3.84±0.17 kcal mol−1Formula:C10H9NPurity:Min. 95%Molecular weight:143.18 g/mol2-(Benzylamino)benzonitrile
CAS:2-(Benzylamino)benzonitrile is an organometallic reagent that is used in the synthesis of heterocyclic compounds. It can be used to form anions with various halides, such as 2-aminobenzaldehyde and quinazolines. The chemical rearrangements of acyl halides are a common reaction that occurs when 2-(benzylamino)benzonitrile is exposed to acid or base. This reaction produces 6-membered heterocycles, which have been shown to have therapeutic potential against cancer cells.
Formula:C14H12N2Purity:Min. 95%Molecular weight:208.26 g/mol4-Hydroxy-3,4-diphenylcyclopent-2-en-1-one
CAS:Versatile small molecule scaffold
Formula:C17H14O2Purity:Min. 95%Molecular weight:250.29 g/mol2-Methyl-3-phenylbutan-2-amine hydrochloride
CAS:Controlled ProductVersatile small molecule scaffold
Formula:C11H18ClNPurity:Min. 95%Molecular weight:199.72 g/mol6-Aminopyridine-2-carbohydrazide
CAS:Versatile small molecule scaffoldFormula:C6H8N4OPurity:Min. 95%Molecular weight:152.15 g/mol3-Amino-6-chloro-3,4-dihydroquinazolin-4-one
CAS:Versatile small molecule scaffoldFormula:C8H6ClN3OPurity:Min. 95%Molecular weight:195.6 g/mol2-(5-Methyloxolan-2-yl)acetic acid
CAS:Versatile small molecule scaffold
Formula:C7H12O3Purity:Min. 95%Molecular weight:144.17 g/mol2-Chloro-1-(5-nitrofuran-2-yl)ethan-1-one
CAS:2-Chloro-1-(5-nitrofuran-2-yl)ethan-1-one is a molecule that belongs to the class of fatty alcohols. This drug is used in pharmaceutical preparations, specifically in pharmaceutical dosages, as an anti-inflammatory and bronchiolitis obliterans agent. The target tissue for this drug is the respiratory tract. 2CHNEE has been shown to inhibit the growth of cancer cells by targeting them with monoclonal antibodies that block their ability to synthesize fatty acids and fatty acid derivatives. It also inhibits fungal growth by binding to ergosterol, which prevents it from being converted into ergosterol peroxide and disrupting cell membranes.
Formula:C6H4ClNO4Purity:Min. 95%Molecular weight:189.55 g/molIopydol
CAS:Iopydol is a drug that binds to specific proteins in the body, such as those found in the bowel, and causes a change in their structure or function. Iopydol is used to treat inflammatory bowel disease. It has also been shown to have an anti-inflammatory effect on other inflammatory diseases, such as rheumatoid arthritis and asthma. Iopydol has been shown to be effective at reducing the symptoms of infectious diseases, such as malaria and tuberculosis. This drug may also have therapeutic effects against cancer by binding to cancerous cells, which prevents them from proliferating and spreading.Formula:C8H9I2NO3Purity:Min. 95%Molecular weight:420.97 g/mol5-Methyl-5-phenylpyrrolidin-2-one
CAS:5-Methyl-5-phenylpyrrolidin-2-one (MPP+) is an analog of butyric acid and the active substance in the neurotoxin MPTP. MPP+ causes death by inhibiting dopamine production, leading to Parkinson's disease. It also inhibits GABA synthesis and activates glutamate receptors. MPP+ has been shown to be toxic to rat brain cells in culture, causing neuronal degeneration. Injection of rats with MPP+ leads to decreased reflexes and a decrease in γ-aminobutyric acid (GABA) concentrations in the brain.
Formula:C11H13NOPurity:Min. 95%Molecular weight:175.23 g/mol1-Nitro-4-(2-nitroethenyl)benzene
CAS:Versatile small molecule scaffold
Formula:C8H6N2O4Purity:Min. 95%Molecular weight:194.14 g/molEthyl 1,2,3,4-tetrahydroquinoline-6-carboxylate
CAS:Versatile small molecule scaffold
Formula:C12H15NO2Purity:Min. 95%Molecular weight:205.25 g/mol4-Chloro-1-(propan-2-yl)piperidine hydrochloride
CAS:Versatile small molecule scaffoldFormula:C8H17Cl2NPurity:Min. 95%Molecular weight:198.1 g/mol2-(3-Nitrophenyl)-1,3,4-oxadiazole
CAS:The synthesis of 2-nitrophenyl-1,3,4-oxadiazole is achieved by condensation of hydrazides and orthoesters. The catalytic solvents used in the reaction are trifluoroacetic acid or acetic anhydride. The use of this methodology has been shown to be efficient and can be used for the synthesis of other derivatives. This method is also efficient and does not require more than one reagent or catalyst. It is toxic to humans but does not have any mutagenic effects on DNA.Formula:C8H5N3O3Purity:Min. 95%Molecular weight:191.14 g/molEthyl 5-hydroxy-2-methyl-1-phenyl-1H-indole-3-carboxylate
CAS:Controlled ProductEthyl 5-hydroxy-2-methyl-1-phenyl-1H-indole-3-carboxylate is a linker molecule that is used in the synthesis of bioreductive agents. It has been shown to inhibit cell growth in human K562 cells, as well as ascidian eggs and to be involved in the transfer of genetic information from DNA to RNA. Ethyl 5-hydroxy-2-methyl-1-phenyl-1H-indole-3 carboxylate has also been synthesized, and its molecular modeling studies have revealed that it inhibits tumour cells by interfering with Ezh2 inhibitors.Formula:C18H17NO3Purity:Min. 95%Molecular weight:295.3 g/mol3-Benzoylpiperidine HCl
CAS:Versatile small molecule scaffoldFormula:C12H15NO·HClPurity:Min. 95%Molecular weight:225.72 g/mol2-(3-Piperidyl)acetonitrile hydrochloride
CAS:Versatile small molecule scaffoldFormula:C7H13ClN2Purity:Min. 95%Molecular weight:160.64 g/molN-Acetylimidazole
CAS:N-Acetylimidazole is a drug that belongs to the class of glycol esters. It is an inhibitor of the enzyme acetylcholinesterase and has been used in the treatment of autoimmune diseases, such as myasthenia gravis. N-Acetylimidazole can inhibit the activity of other enzymes, such as p-nitrophenyl phosphate oxidase, which may be responsible for its anti-inflammatory properties. This drug has been shown to inhibit microbial growth in vitro by inhibiting the synthesis of choline and acetylcholine in the body. N-Acetylimidazole also inhibits bacterial growth by acting as a substrate molecule for bacterial enzymes that catalyze transfer reactions, including phosphotransferases and hydrolases.
Formula:C5H6N2OPurity:Min. 95%Color and Shape:White PowderMolecular weight:110.11 g/mol4-(1,2-Oxazol-5-yl)oxane-4-carboxylic acid
CAS:Versatile small molecule scaffold
Formula:C9H11NO4Purity:Min. 95%Molecular weight:197.2 g/moltert-Butyl 4-amino-5-(hydroxymethyl)azepane-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C12H24N2O3Purity:Min. 95%Molecular weight:244.33 g/mol3-Phenyl-2-azabicyclo[2.2.1]heptane
CAS:Versatile small molecule scaffoldFormula:C12H15NPurity:Min. 95%Molecular weight:173.3 g/mol5-Bromo-3-methylbenzene-1,2-diol
CAS:Versatile small molecule scaffold
Formula:C7H7BrO2Purity:Min. 95%Molecular weight:203.03 g/mol1-(3-Methoxy-1,2-thiazol-4-yl)ethan-1-one
CAS:Versatile small molecule scaffoldFormula:C6H7NO2SPurity:Min. 95%Molecular weight:157.19 g/mol3-(Hydroxymethyl)-5-methyl-1,2-oxazole-4-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C6H7NO4Purity:Min. 95%Molecular weight:157.12 g/mol8-Hydroxy-3,4-dihydro-2H-1,3-benzoxazin-2-one
CAS:Versatile small molecule scaffoldFormula:C8H7NO3Purity:Min. 95%Molecular weight:165.15 g/mol6-Hydroxy-3,4-dihydro-2H-1,3-benzoxazin-2-one
CAS:Versatile small molecule scaffoldFormula:C8H7NO3Purity:Min. 95%Molecular weight:165.15 g/molMethyl 3,5-difluoro-4-(hydroxymethyl)benzoate
CAS:Versatile small molecule scaffoldFormula:C9H8F2O3Purity:Min. 95%Molecular weight:202.15 g/mol1-(Oxan-4-yl)-1H-pyrazole-5-carbaldehyde
CAS:Versatile small molecule scaffoldFormula:C9H12N2O2Purity:Min. 95%Molecular weight:180.2 g/mol3-(2-Cyclopentyl-1H-imidazol-1-yl)propan-1-amine
CAS:Versatile small molecule scaffoldFormula:C11H19N3Purity:Min. 95%Molecular weight:193.29 g/mol4,4-difluoropyrrolidine-3-carboxylic acid hydrochloride
CAS:Versatile small molecule scaffoldFormula:C5H8ClF2NO2Purity:Min. 95%Molecular weight:187.57 g/mol6-Fluoro-2,3-dihydro-1-benzofuran-7-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C9H7FO3Purity:Min. 95%Molecular weight:182.15 g/moltert-Butyl 3-(2-methoxy-2-oxoethyl)-4-oxopyrrolidine-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C12H19NO5Purity:Min. 95%Molecular weight:257.3 g/mol1-Methyl-3-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid
CAS:Versatile small molecule scaffold
Formula:C9H6F3N3O2Purity:Min. 95%Molecular weight:245.16 g/molMethyl 5-{[(tert-butoxy)carbonyl]amino}-1,2-oxazole-3-carboxylate
CAS:Versatile small molecule scaffold
Formula:C10H14N2O5Purity:Min. 95%Molecular weight:242.23 g/mol1-Bromo-3-(trifluoromethyl)imidazo[1,5-a]pyrazine
CAS:Versatile small molecule scaffoldFormula:C7H3BrF3N3Purity:Min. 95%Molecular weight:266.02 g/mol1-Methyl-1H-pyrazolo[3,4-c]pyridin-3-ol
CAS:Versatile small molecule scaffold
Formula:C7H7N3OPurity:Min. 95%Molecular weight:149.15 g/mol(3-Fluorocyclohexyl)methanesulfonyl chloride
CAS:Versatile small molecule scaffold
Formula:C7H12ClFO2SPurity:Min. 95%Molecular weight:214.69 g/mol3-{[(tert-Butoxy)carbonyl]amino}-2,2-dimethylcyclobutane-1-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C12H21NO4Purity:Min. 95%Molecular weight:243.3 g/mol3-Fluoro-2,2-dimethylpropane-1-sulfonyl chloride
CAS:Versatile small molecule scaffoldFormula:C5H10ClFO2SPurity:Min. 95%Molecular weight:188.65 g/mol1,8-Dioxaspiro[4.5]decan-4-amine
CAS:Versatile small molecule scaffoldFormula:C8H15NO2Purity:Min. 95%Molecular weight:157.21 g/moltert-Butyl N-[(3-hydroxypiperidin-3-yl)methyl]carbamate
CAS:Versatile small molecule scaffold
Formula:C11H22N2O3Purity:Min. 95%Molecular weight:230.3 g/molMethyl 2-(methylamino)-2-(oxetan-3-yl)acetate
CAS:Versatile small molecule scaffoldFormula:C7H13NO3Purity:Min. 95%Molecular weight:159.2 g/molMethyl 5-azaspiro[3.4]octane-6-carboxylate
CAS:Versatile small molecule scaffoldFormula:C9H15NO2Purity:Min. 95%Molecular weight:169.2 g/moltert-Butyl 2-(3-aminopropyl)morpholine-4-carboxylate
CAS:Versatile small molecule scaffoldFormula:C12H24N2O3Purity:Min. 95%Molecular weight:244.33 g/mol2-[(tert-Butoxy)carbonyl]-2-azabicyclo[4.1.0]heptane-3-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C12H19NO4Purity:Min. 95%Molecular weight:241.28 g/mol(5-Bromo-1H-pyrazol-3-yl)methanol
CAS:Versatile small molecule scaffold
Formula:C4H5BrN2OPurity:Min. 95%Molecular weight:177 g/mol4-{[(tert-Butoxy)carbonyl]amino}oxane-2-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C11H19NO5Purity:Min. 95%Molecular weight:245.27 g/molMethyl 4-(2-oxoethyl)cyclohexane-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C10H16O3Purity:Min. 95%Molecular weight:184.23 g/mol
